Background Obesity and obstructive sleep apnea tend to coexist and are associated with
inflammation, insulin resistance, dyslipidemia, and high blood pressure, but their causal …

Background Obstructive sleep apnea is associated with an increased prevalence of the
metabolic syndrome and its components. It is unclear whether treatment of obstructive sleep …

Background Continuous positive airway pressure (CPAP) in patients with obstructive sleep
apnea syndrome (OSAS) might lower blood pressure, but evidence from clinical studies is …

Background Obstructive sleep apnea is associated with hypertension, inflammation, and
increased cardiovascular risk. Continuous positive airway pressure (CPAP) reduces blood …

Importance Obesity is the leading cause of obstructive sleep apnea (OSA); however, the
effects of weight loss and lifestyle interventions on OSA and comorbidities remain uncertain …

Background CPAP reduces blood pressure (BP) in patients with symptomatic obstructive
sleep apnoea (OSA). Whether the same benefit is present in patients with minimally …

Introduction The impact of obstructive sleep apnoea (OSA) treatment with CPAP on weight is
not clear. This meta-analysis was designed to assess whether OSA treatment with CPAP …

Obstructive sleep apnea is a common disorder that has been associated with an increased
risk of cardiovascular disease. 1 Continuous positive airway pressure (CPAP) is frequently …

Background Obstructive sleep apnea is associated with an increased risk of cardiovascular
events; whether treatment with continuous positive airway pressure (CPAP) prevents major …

Background Obstructive sleep apnea (OSA) is associated with obesity, insulin resistance
(IR) and diabetes. Continuous positive airway pressure (CPAP) rapidly mitigates OSA in …